Anzeige
❌
Mehr »
Freitag, 09.10.2026 - Börsentäglich über 12.000 News
Elevate Sercive Group: Neue Expertise für den nächsten Wachstumsschritt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
JB

WKN: A41ARP | ISIN: NL0015002J37 | Ticker-Symbol: Z98
Tradegate
08.10.26 | 19:55
11,280 Euro
-0,84 % -0,095
1-Jahres-Chart
JBS NV Chart 1 Jahr
5-Tage-Chart
JBS NV 5-Tage-Chart
RealtimeGeldBriefZeit
11,45011,48516:17
11,43011,50516:17

Aktuelle News zur JBS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:58Pilgrim's Pride board to review takeover approach by Brazil's JBS2
14:36Pilgrim's Pride Corporation: Pilgrim's Pride Forms Special Committee and Selects Advisors to Review JBS N.V. Proposal80GREELEY, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- The board of directors of Pilgrim's Pride Corporation (NASDAQ: PPC) ("PPC") has formed a special committee of independent and disinterested directors...
► Artikel lesen
22.09.JBS shifts Brazilian debt issuance to Dutch parent8
21.09.JBS embraces protein trend with branch-out of Genu-in subsidiary-
15.09.JBS N.V. - 8-K, Current Report4
JBS Aktie jetzt für 0€ handeln
15.09.Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026499Prostate cancer and Alzheimer's disease imaging programs position the Company for FDA submissions in 2027 across two of the fastest-growing segments in molecular imagingBEDMINSTER, N.J., Sept. 15, 2026...
► Artikel lesen
04.09.Trump-Erlass zu Rindfleisch belastet Aktien von JBS und Tyson Foods47
04.09.JBS to ramp up egg production in Brazil2
01.09.Juniper Biosciences: Juniper's JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer550BEDMINSTER, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole...
► Artikel lesen
01.09.JBS co-owner lobbied Trump to lower beef import tariffs, WSJ reports1
25.08.Transcript: JBS Q2 2026 Earnings Conference Call11
24.08.JBS owners buy defense company Avibras2
24.08.UBS raises JBS stock price target on improved 2027-28 outlook4
20.08.JBS Makes New Bid For Full Control, Delisting Of Pilgrim's Pride4
20.08.JBS seeking total control of Pilgrim's Pride Corp.: JBS currently owns approximately 88% of the poultry processor2
20.08.JBS Proposes To Acquire Remaining 18% Of Pilgrim's Pride In All-Stock Deal2
19.08.JBS proposes taking Pilgrim's Pride private1
19.08.JBS makes bid for remainder of Pilgrim's Pride2
19.08.JBS Übernahmeangebot treibt Aktie von Pilgrim's Pride an11
19.08.JBS revisits bid to take control of Pilgrim's Pride1
1 2 3 4 5 Weiter >>
105 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1